The quarter ending March 2026 marked a sharp reversal from the previous quarter's profit of ₹0.36 crores, with net profit swinging to a loss of ₹0.16 crores. However, revenue demonstrated resilience with net sales reaching ₹13.59 crores in Q4 FY26, representing a robust 30.80% year-on-year growth compared to ₹10.39 crores in Q4 FY25. On a sequential basis, revenue declined 20.57% from the previous quarter's ₹17.11 crores, reflecting typical seasonal patterns in the agrochemical sector.
For the full financial year FY25, Super Crop Safe reported consolidated revenue of ₹45.00 crores, marking a significant 45.20% year-on-year increase from ₹31.00 crores in FY24. Annual net profit stood at ₹2.00 crores, doubling from ₹1.00 crore in the previous year. The company's operating profit margin for FY25 was 8.90%, whilst the PAT margin improved to 4.40% from 3.20% in FY24.
Financial Performance: Margin Compression Overshadows Revenue Gains
The fourth quarter witnessed severe margin compression across all profitability metrics. Operating profit (PBDIT excluding other income) stood at ₹0.35 crores in Q4 FY26, translating to an operating margin of just 2.58%, a dramatic decline from 10.33% in Q4 FY25 and 3.74% in the preceding quarter. This represents one of the weakest margin performances in recent quarters, signalling heightened cost pressures and operational challenges.
| Quarter | Revenue (₹ Cr) | QoQ Growth | YoY Growth | Operating Margin | PAT Margin |
|---|---|---|---|---|---|
| Mar'26 | 13.59 | -20.57% | +30.80% | 2.58% | -1.18% |
| Dec'25 | 17.11 | +16.47% | +36.23% | 3.74% | 2.10% |
| Sep'25 | 14.69 | +54.79% | +19.92% | 7.83% | 5.04% |
| Jun'25 | 9.49 | -8.66% | — | 10.33% | 5.27% |
| Mar'25 | 10.39 | -17.28% | — | 0.38% | -5.29% |
| Dec'24 | 12.56 | +2.53% | — | 11.15% | 7.25% |
| Sep'24 | 12.25 | — | — | 8.90% | 4.65% |
Interest costs remained elevated at ₹0.40 crores in Q4 FY26, substantially higher than ₹0.23 crores in the previous quarter, contributing to the profit squeeze. Depreciation was steady at ₹0.11 crores. Employee costs increased to ₹0.64 crores from ₹0.59 crores sequentially, though they remained lower than the ₹0.87 crores recorded in Q2 FY26. The gross profit margin deteriorated to negative 0.44% in Q4 FY26 from 2.51% in Q3 FY26, indicating severe pressure on the bottom line after accounting for all operating expenses.
Operational Challenges: Weak Returns and High Leverage
Super Crop Safe's operational efficiency metrics paint a concerning picture of the company's fundamental health. The average return on capital employed (ROCE) stands at a weak 1.42%, whilst the latest ROCE for FY26 improved marginally to 4.24%. These figures remain significantly below industry standards, indicating that the company generates minimal returns on the capital deployed in its operations. The average return on equity (ROE) of 4.39% further underscores the challenge, with the latest ROE at 3.45%, suggesting limited profitability for shareholders.
Critical Concern: Deteriorating Capital Efficiency
Weak ROCE of 1.42% (average) indicates the company is struggling to generate adequate returns on invested capital. Higher ROCE values signal better capital efficiency and profitability—Super Crop Safe's low ROCE is a significant red flag requiring immediate management attention. The company's sales to capital employed ratio of just 0.65x further highlights suboptimal asset utilisation.
The balance sheet reveals mounting leverage concerns. Long-term debt surged to ₹29.27 crores in FY25 from ₹22.31 crores in FY24, representing a substantial 31.20% increase. The average debt-to-EBITDA ratio stands at 3.54, indicating moderate but manageable debt levels relative to earnings. However, the average net debt-to-equity ratio of 1.38 reflects high leverage, with debt significantly exceeding shareholder equity. Current assets stood at ₹71.74 crores against current liabilities of ₹31.64 crores, providing some liquidity cushion, though working capital management appears to be a persistent challenge.
The EBIT-to-interest coverage ratio averages just 0.46x, meaning the company's operating profit is insufficient to cover interest obligations—a serious solvency concern. This weak coverage ratio explains the profit volatility and raises questions about the sustainability of the current debt structure. Trade payables declined to ₹12.44 crores in FY25 from ₹16.08 crores in FY24, suggesting improved supplier payment discipline, though this may have strained cash flows.
Agrochemical Sector Dynamics: Navigating Headwinds
The pesticides and agrochemicals sector has faced multiple headwinds over the past year, including channel inventory destocking, volatile raw material prices, and intense competition from Chinese imports. Super Crop Safe's 30.80% year-on-year revenue growth in Q4 FY26 stands in contrast to the broader sector's 15.07% decline over the past year, suggesting the company may be gaining market share or benefiting from specific product mix advantages.
Sector Context: Mixed Signals
Whilst Super Crop Safe achieved strong revenue growth of 30.80% in Q4 FY26, the company's stock has underperformed the sector by 16.52 percentage points over the past year, with a negative 31.59% return compared to the sector's negative 15.07%. This divergence between operational performance and market perception suggests investors remain sceptical about the sustainability of growth and profitability.
The company's five-year sales growth of just 2.33% annually reflects the cyclical and challenging nature of the agrochemical business. However, EBIT growth of 23.15% over the same period indicates improving operational leverage, though this has been inconsistent quarter to quarter. The agricultural sector's dependence on monsoon patterns, crop prices, and farmer sentiment creates inherent volatility that companies like Super Crop Safe must navigate.
Peer Comparison: Valuation Premium Without Quality Justification
Super Crop Safe trades at a price-to-earnings ratio of 40.33x, significantly above the industry average of approximately 32x and higher than most direct peers. This valuation premium appears unjustified given the company's weak profitability metrics and below-average quality grade. The price-to-book value of 1.39x is modest but still reflects some premium to book value despite the operational challenges.
| Company | P/E (TTM) | P/BV | Dividend Yield | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Super Crop Safe | 40.33 | 1.39 | N/A | 42.00 |
| Shivalik Rasayan | 39.07 | 0.77 | 0.17% | — |
| Mahamaya Lifesciences | 22.68 | 3.09 | N/A | — |
| Bhaskar Agrochemicals | 12.01 | 3.73 | 0.67% | — |
| Aimco Pesticides | NA (Loss Making) | 2.16 | N/A | — |
| Adarsh Plant | NA (Loss Making) | 30.18 | N/A | — |
Compared to peers like Bhaskar Agrochemicals (P/E of 12.01x with superior 12.53% ROE) and Mahamaya Lifesciences (P/E of 22.68x), Super Crop Safe's valuation appears stretched. The company does not pay dividends, unlike some peers, further questioning the premium valuation. With zero institutional holdings and declining promoter stake, the stock lacks the quality markers that typically justify premium multiples.
Valuation Analysis: Attractive Grade Masks Fundamental Weakness
Despite the company's operational challenges, Super Crop Safe currently carries an "Attractive" valuation grade, having been upgraded from "Fair" in January 2025. The stock trades at ₹9.92, down 33.87% from its 52-week high of ₹15.00 but up 45.45% from its 52-week low of ₹6.82. The EV-to-EBITDA multiple of 30.00x and EV-to-EBIT of 35.41x remain elevated, suggesting the market is pricing in significant future growth that may not materialise given current trends.
The "Attractive" valuation grade appears to be a technical assessment based on recent price declines rather than a reflection of fundamental value. With weak returns on capital, high leverage, and inconsistent profitability, the intrinsic value of the business remains questionable. The company last paid a dividend of ₹0.10 per share in September 2018, and there are no signs of dividend resumption in the near term.
Shareholding Pattern: Steady Promoter Dilution Raises Questions
Promoter shareholding has witnessed consistent erosion over the past five quarters, declining from 34.52% in March 2025 to 32.36% in March 2026. This represents a cumulative decline of 2.16 percentage points, with the most significant drop of 1.34 percentage points occurring between June and September 2025. Non-institutional investors have correspondingly increased their stake from 65.48% to 67.64% over the same period.
| Quarter | Promoter % | QoQ Change | FII % | MF % | Non-Institutional % |
|---|---|---|---|---|---|
| Mar'26 | 32.36% | -0.12% | 0.00% | 0.00% | 67.64% |
| Dec'25 | 32.48% | -0.24% | 0.00% | 0.00% | 67.52% |
| Sep'25 | 32.72% | -1.34% | 0.00% | 0.00% | 67.28% |
| Jun'25 | 34.06% | -0.46% | 0.00% | 0.00% | 65.94% |
| Mar'25 | 34.52% | — | 0.00% | 0.00% | 65.48% |
The gradual but persistent reduction in promoter holding, whilst not alarming in absolute terms, raises questions about promoter confidence in the company's prospects. Positively, there is no promoter pledging, which eliminates one source of risk. However, the complete absence of institutional investors—zero FII, mutual fund, insurance, and other DII holdings—is a significant red flag. Institutional investors typically conduct rigorous due diligence, and their absence suggests concerns about governance, growth prospects, or financial stability.
Stock Performance: Severe Underperformance Across Timeframes
Super Crop Safe has delivered disappointing returns across most timeframes, significantly underperforming both the Sensex and its sector. Over the past year, the stock declined 31.59% compared to the Sensex's 8.82% decline, resulting in a negative alpha of 22.77 percentage points. The two-year performance shows a decline of 24.85%, whilst the Sensex gained 0.41% during the same period.
| Period | Stock Return | Sensex Return | Alpha |
|---|---|---|---|
| 1 Day | -6.50% | -0.68% | -5.82% |
| 1 Week | -4.15% | -2.90% | -1.25% |
| 1 Month | +4.97% | -3.44% | +8.41% |
| 3 Months | +16.16% | -8.64% | +24.80% |
| 6 Months | +16.71% | -13.28% | +29.99% |
| YTD | +5.98% | -12.85% | +18.83% |
| 1 Year | -31.59% | -8.82% | -22.77% |
| 2 Years | -24.85% | +0.41% | -25.26% |
| 3 Years | +48.95% | +18.96% | +29.99% |
Recent performance has shown some improvement, with the stock gaining 16.16% over three months and 16.71% over six months, significantly outperforming the Sensex during these periods. However, this recovery from deeply oversold levels does not negate the longer-term underperformance. The stock's beta of 1.50 indicates high volatility, with movements 50% more pronounced than the broader market. The risk-adjusted return of negative 0.58 over one year, combined with 54.74% volatility, places the stock firmly in the "high risk, low return" category.
The stock currently trades below all key moving averages—5-day (₹10.60), 20-day (₹9.81), 50-day (₹8.93), 100-day (₹8.97), and 200-day (₹9.86)—though it is positioned just above the 50-day and 100-day averages. Technical indicators present mixed signals, with MACD showing mildly bullish on the weekly chart but bearish monthly, whilst Bollinger Bands indicate bullish weekly but mildly bearish monthly trends. The overall technical trend is classified as "mildly bearish," having shifted from "bearish" in April 2026.
Investment Thesis: Quality Concerns Overshadow Valuation
Super Crop Safe's investment case presents a challenging picture characterised by fundamental weaknesses that overshadow any apparent valuation attraction. The company carries a "Below Average" quality grade, reflecting weak long-term financial performance with an average ROCE of just 1.42% and average ROE of 4.39%. The five-year sales growth of 2.33% is anaemic, whilst debt levels remain elevated with a debt-to-EBITDA ratio of 3.54 and net debt-to-equity of 1.38.
The proprietary Mojo Score of 34 out of 100 places the stock firmly in "SELL" territory, with the recommendation to "consider selling and look for exit opportunities." This score reflects the confluence of negative factors: bearish technical trend, weak fundamental strength, and significant market underperformance. Whilst the short-term financial trend turned "Positive" in March 2026 based on the 30.80% revenue growth, this single positive metric is insufficient to offset the broader concerns.
Key Strengths & Risk Factors
KEY STRENGTHS
- Strong revenue growth of 30.80% YoY in Q4 FY26 demonstrates market traction
- Full-year FY25 revenue growth of 45.20% shows sustained top-line momentum
- No promoter pledging eliminates governance risk from leveraged promoter holdings
- Attractive valuation grade provides potential entry point for risk-tolerant investors
- Recent three-month and six-month stock performance shows recovery from lows
KEY CONCERNS
- Net loss of ₹0.16 crores in Q4 FY26 despite revenue growth signals severe operational issues
- Operating margin collapsed to 2.58% from 10.33% YoY, indicating unsustainable cost structure
- Weak ROCE of 1.42% and ROE of 4.39% reflect poor capital efficiency
- High leverage with debt-to-equity of 1.38 and insufficient EBIT-to-interest coverage of 0.46x
- Zero institutional holdings and declining promoter stake signal lack of confidence
- Stock underperformed market by 22.77 percentage points over past year
- High volatility (54.74%) with negative risk-adjusted returns
Outlook: Critical Monitoring Points
POSITIVE CATALYSTS
- Sustained improvement in operating margins above 8% for two consecutive quarters
- Return to consistent profitability with PAT margins stabilising above 4%
- Debt reduction bringing net debt-to-equity below 1.0x
- Entry of institutional investors or increase in promoter stake
- ROCE improvement above 8% demonstrating better capital allocation
RED FLAGS TO WATCH
- Further margin compression below 2% or consecutive quarterly losses
- Additional promoter stake reduction below 30%
- Breach of debt covenants or inability to service interest obligations
- Revenue decline for two consecutive quarters signalling demand weakness
- Stock breaking below 52-week low of ₹6.82 on high volumes
The company faces a critical juncture where management must demonstrate the ability to translate top-line growth into bottom-line profitability. The Q1 FY27 results, expected in the coming months, will be pivotal in determining whether the Q4 FY26 loss was an aberration or the beginning of a more troubling trend. Investors should closely monitor quarterly margin trends, debt servicing capacity, and any changes in shareholding patterns.
The Verdict: Avoid—Fundamental Weaknesses Outweigh Valuation Appeal
Score: 34/100
For Fresh Investors: Avoid initiating positions. The combination of weak profitability, poor capital efficiency, high leverage, and lack of institutional support makes this a high-risk proposition. The "Attractive" valuation grade is a technical assessment that does not reflect the underlying business quality concerns. Better opportunities exist in the agrochemical space with stronger fundamentals.
For Existing Holders: Consider reducing positions on any technical bounce towards the ₹11-12 range. The deteriorating margin profile and return to losses in Q4 FY26 suggest operational challenges that may persist. Maintain a strict stop-loss at ₹8.50 (near 100-day moving average). Only hold if you have high risk tolerance and believe in management's ability to execute a turnaround.
Fair Value Estimate: ₹7.50 (24.40% downside from current price of ₹9.92)
The fair value estimate is based on a conservative 25x P/E multiple applied to normalised earnings of ₹0.30 per share, assuming the company can return to FY25 profitability levels. However, given current operational trends and elevated debt, even this estimate carries execution risk. The stock would need to demonstrate at least two consecutive quarters of margin improvement and consistent profitability before a more constructive view can be adopted.
Note— ROCE= (EBIT - Other income)/(Capital Employed - Cash - Current Investments)
⚠️ Investment Disclaimer
This article is for educational and informational purposes only and should not be construed as financial advice. Investors should conduct their own due diligence, consider their risk tolerance and investment objectives, and consult with a qualified financial advisor before making any investment decisions.
